{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06220721",
            "orgStudyIdInfo": {
                "id": "PRO00049909"
            },
            "organization": {
                "fullName": "Medical College of Wisconsin",
                "class": "OTHER"
            },
            "briefTitle": "Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following Preeclampsia",
            "officialTitle": "Reducing the Risk of Chronic Hypertension and Improving Vascular Function Following",
            "acronym": "REPAIR",
            "therapeuticArea": [
                "Women's Health"
            ],
            "study": "reducing-the-risk-of-chronic-hypertension-and-improving-vascular-function-following-preeclampsia"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2029-06-30",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-06-30",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-15",
            "studyFirstSubmitQcDate": "2024-01-23",
            "studyFirstPostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-23",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-24",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Anna Palatnik, MD",
                "investigatorTitle": "Associate Professor",
                "investigatorAffiliation": "Medical College of Wisconsin"
            },
            "leadSponsor": {
                "name": "Medical College of Wisconsin",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.",
            "detailedDescription": "The REPAIR trial will randomize 618 postpartum patients with HDP to intensive blood pressure (BP) control with Nifedipine extended release (ER) (target BP \\<140/90 mmHg) versus active control group (target BP \\<150/100 mmHg) for 6 weeks postpartum, using home BP monitoring program at two clinical sites: Medical College of Wisconsin (MCW) and Northwestern University (NU). All participants will undergo vascular function assessment: endothelial dysfunction with brachial artery flow mediated dilation (FMD), arterial stiffness with carotid-femoral pulse wave velocity (cfPWV), and collection of an anti-angiogenic biomarker, soluble fms-like tyrosine kinase (sFlt-1), at baseline, 6 weeks, and 12 months postpartum. The primary outcome is the rate of new diagnosis of chronic HTN at one year postpartum. Secondary outcomes are improvement in vascular function, assessed by FMD, cfPWV, and sFlt-1, from baseline to 12 months postpartum. Sub-group analyses will be done to examine study outcomes by HDP type (gestational HTN vs. preeclampsia) and by patients that maintained BP \\<130/80 mmHg versus higher"
        },
        "conditionsModule": {
            "conditions": [
                "Hypertensive Disorder of Pregnancy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "Parallel Assignment",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 618,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "REPAIR ARM",
                    "type": "EXPERIMENTAL",
                    "description": "Intensive postpartum BP control with Nifedipine ER initiation at SBP\u2265140 mmHg or DBP\u226590 mmHg and maintaining BP at \\<140/90 mmHg during the first 6 weeks postpartum",
                    "interventionNames": [
                        "Drug: NIFEdipine ER"
                    ]
                },
                {
                    "label": "CONTROL ARM",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "A group of usual care with Nifedipine ER initiation at SBP\u2265150 mmHg or DBP\u2265100 mmHg and maintaining BP at \\<150/100 mmHg during the first 6 weeks postpartum.",
                    "interventionNames": [
                        "Drug: NIFEdipine ER"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NIFEdipine ER",
                    "description": "Initiation of Nifedipine ER postpartum at SBP\u2265140 mmHg or DBP\u226590 mmHg and maintaining BP at \\<140/90 mmHg during the first 6 weeks postpartum.",
                    "armGroupLabels": [
                        "CONTROL ARM",
                        "REPAIR ARM"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Chronic hypertension",
                    "description": "Diagnosis of chronic hypertension one year postpartum",
                    "timeFrame": "One year postpartum"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Flow-mediated dilation",
                    "description": "Brachial artery flow-mediated dilation will assess endothelial dysfunction.",
                    "timeFrame": "One year postpartum"
                },
                {
                    "measure": "Arterial stiffness",
                    "description": "Carotid-femoral pulse wave velocity will be done to assess arterial stiffness",
                    "timeFrame": "One year postpartum"
                },
                {
                    "measure": "Unplanned healthcare utilization",
                    "description": "Number of hospital visits after delivery discharge",
                    "timeFrame": "Through one year postpartum"
                },
                {
                    "measure": "Composite severe maternal morbidity",
                    "description": "Includes the following maternal core outcomes of preeclampsia using PMID: 32674052 reference",
                    "timeFrame": "Through one year postpartum"
                },
                {
                    "measure": "Life's Essential 8 cardiovascular health score (range 0-100)",
                    "description": "The score will be calculated using American Heart Association application",
                    "timeFrame": "One year postpartum"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Hypertensive disorders of pregnancy (HDP) diagnosis (gestational hypertension or preeclampsia) according to ACOG guidelines\n* Postpartum day 0-3 and prior to discharge\n* Able to communicate in English or in Spanish\n* Age 18 - 50\n\nExclusion Criteria:\n\n* Pre-gestational hypertension\n* Pre-gestational diabetes ( type 1 or type 2)\n* Intent to transfer postpartum to an outside institution of the participating centers\n* Known allergy to nifedipine or other significant contraindication to nifedipine\n* Inability or unwillingness to provide informed consent",
            "healthyVolunteers": true,
            "sex": "FEMALE",
            "genderBased": true,
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Anna Palatnik, MD",
                    "role": "CONTACT",
                    "phone": "14147916817",
                    "email": "apalatnik@mcw.edu"
                },
                {
                    "name": "Zaira Peterson",
                    "role": "CONTACT",
                    "phone": "(414) 805-1124",
                    "email": "zpeterson@mcw.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Northwestern University",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lynn Yee, MD",
                            "role": "CONTACT",
                            "email": "lynn.yee@northwestern.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "32674052",
                    "type": "BACKGROUND",
                    "citation": "Duffy JMN, Cairns AE, Magee LA, von Dadelszen P, van 't Hooft J, Gale C, Brown M, Chappell LC, Grobman WA, Fitzpatrick R, Karumanchi SA, Lucas DN, Mol B, Stark M, Thangaratinam S, Wilson MJ, Williamson PR, Ziebland S, McManus RJ; International Collaboration to Harmonise Outcomes for Pre-eclampsia (iHOPE). Standardising definitions for the pre-eclampsia core outcome set: A consensus development study. Pregnancy Hypertens. 2020 Jul;21:208-217. doi: 10.1016/j.preghy.2020.06.005. Epub 2020 Jun 20."
                },
                {
                    "pmid": "29215510",
                    "type": "BACKGROUND",
                    "citation": "Too G, Wen T, Boehme AK, Miller EC, Leffert LR, Attenello FJ, Mack WJ, D'Alton ME, Friedman AM. Timing and Risk Factors of Postpartum Stroke. Obstet Gynecol. 2018 Jan;131(1):70-78. doi: 10.1097/AOG.0000000000002372."
                },
                {
                    "pmid": "28228456",
                    "type": "BACKGROUND",
                    "citation": "Wu P, Haththotuwa R, Kwok CS, Babu A, Kotronias RA, Rushton C, Zaman A, Fryer AA, Kadam U, Chew-Graham CA, Mamas MA. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017 Feb;10(2):e003497. doi: 10.1161/CIRCOUTCOMES.116.003497. Epub 2017 Feb 22."
                },
                {
                    "pmid": "33779213",
                    "type": "BACKGROUND",
                    "citation": "Parikh NI, Gonzalez JM, Anderson CAM, Judd SE, Rexrode KM, Hlatky MA, Gunderson EP, Stuart JJ, Vaidya D; American Heart Association Council on Epidemiology and Prevention; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular and Stroke Nursing; and the Stroke Council. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021 May 4;143(18):e902-e916. doi: 10.1161/CIR.0000000000000961. Epub 2021 Mar 29."
                },
                {
                    "pmid": "33351087",
                    "type": "BACKGROUND",
                    "citation": "Hauspurg A, Lemon L, Cabrera C, Javaid A, Binstock A, Quinn B, Larkin J, Watson AR, Beigi RH, Simhan H. Racial Differences in Postpartum Blood Pressure Trajectories Among Women After a Hypertensive Disorder of Pregnancy. JAMA Netw Open. 2020 Dec 1;3(12):e2030815. doi: 10.1001/jamanetworkopen.2020.30815."
                },
                {
                    "pmid": "26636247",
                    "type": "BACKGROUND",
                    "citation": "Shahul S, Tung A, Minhaj M, Nizamuddin J, Wenger J, Mahmood E, Mueller A, Shaefi S, Scavone B, Kociol RD, Talmor D, Rana S. Racial Disparities in Comorbidities, Complications, and Maternal and Fetal Outcomes in Women With Preeclampsia/eclampsia. Hypertens Pregnancy. 2015 Nov;34(4):506-515. doi: 10.3109/10641955.2015.1090581. Epub 2015 Dec 4."
                },
                {
                    "pmid": "33345653",
                    "type": "BACKGROUND",
                    "citation": "Levine L, Arany Z, Kern-Goldberger A, Koelper N, Lewey J, Sammel MD, Elovitz MA, Ky B. Soluble Flt1 levels are associated with cardiac dysfunction in Black women with and without severe preeclampsia. Hypertens Pregnancy. 2021 Feb;40(1):44-49. doi: 10.1080/10641955.2020.1861462. Epub 2020 Dec 20."
                },
                {
                    "pmid": "27754864",
                    "type": "BACKGROUND",
                    "citation": "Grand'Maison S, Pilote L, Okano M, Landry T, Dayan N. Markers of Vascular Dysfunction After Hypertensive Disorders of Pregnancy: A Systematic Review and Meta-Analysis. Hypertension. 2016 Dec;68(6):1447-1458. doi: 10.1161/HYPERTENSIONAHA.116.07907. Epub 2016 Oct 17."
                },
                {
                    "pmid": "31023435",
                    "type": "BACKGROUND",
                    "citation": "Lane-Cordova AD, Khan SS, Grobman WA, Greenland P, Shah SJ. Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes: JACC Review Topic of the Week. J Am Coll Cardiol. 2019 Apr 30;73(16):2106-2116. doi: 10.1016/j.jacc.2018.12.092."
                },
                {
                    "pmid": "26711737",
                    "type": "BACKGROUND",
                    "citation": "Weissgerber TL, Milic NM, Milin-Lazovic JS, Garovic VD. Impaired Flow-Mediated Dilation Before, During, and After Preeclampsia: A Systematic Review and Meta-Analysis. Hypertension. 2016 Feb;67(2):415-23. doi: 10.1161/HYPERTENSIONAHA.115.06554. Epub 2015 Dec 28."
                },
                {
                    "pmid": "29703800",
                    "type": "BACKGROUND",
                    "citation": "Hirshberg A, Downes K, Srinivas S. Comparing standard office-based follow-up with text-based remote monitoring in the management of postpartum hypertension: a randomised clinical trial. BMJ Qual Saf. 2018 Nov;27(11):871-877. doi: 10.1136/bmjqs-2018-007837. Epub 2018 Apr 27."
                },
                {
                    "pmid": "32143061",
                    "type": "BACKGROUND",
                    "citation": "Lopes Perdigao J, Hirshberg A, Koelper N, Srinivas SK, Sammel MD, Levine LD. Postpartum blood pressure trends are impacted by race and BMI. Pregnancy Hypertens. 2020 Apr;20:14-18. doi: 10.1016/j.preghy.2020.02.006. Epub 2020 Feb 26."
                },
                {
                    "pmid": "35550687",
                    "type": "BACKGROUND",
                    "citation": "Stuart JJ, Tanz LJ, Rimm EB, Spiegelman D, Missmer SA, Mukamal KJ, Rexrode KM, Rich-Edwards JW. Cardiovascular Risk Factors Mediate the Long-Term Maternal Risk Associated With Hypertensive Disorders of Pregnancy. J Am Coll Cardiol. 2022 May 17;79(19):1901-1913. doi: 10.1016/j.jacc.2022.03.335."
                },
                {
                    "pmid": "29146535",
                    "type": "BACKGROUND",
                    "citation": "Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13. No abstract available. Erratum In: J Am Coll Cardiol. 2018 May 15;71(19):2275-2279. doi: 10.1016/j.jacc.2018.03.016."
                },
                {
                    "pmid": "35766027",
                    "type": "BACKGROUND",
                    "citation": "Lloyd-Jones DM, Allen NB, Anderson CAM, Black T, Brewer LC, Foraker RE, Grandner MA, Lavretsky H, Perak AM, Sharma G, Rosamond W; American Heart Association. Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association. Circulation. 2022 Aug 2;146(5):e18-e43. doi: 10.1161/CIR.0000000000001078. Epub 2022 Jun 29."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014115",
                    "term": "Toxemia"
                },
                {
                    "id": "D000006973",
                    "term": "Hypertension"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000007239",
                    "term": "Infections"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "asFound": "Hypertensive Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16869",
                    "name": "Toxemia",
                    "asFound": "Hypertensive Disorders of Pregnancy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14106",
                    "name": "Pre-Eclampsia",
                    "relevance": "LOW"
                },
                {
                    "id": "M20864",
                    "name": "Sepsis",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10283",
                    "name": "Infections",
                    "relevance": "LOW"
                },
                {
                    "id": "M6368",
                    "name": "Communicable Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC01",
                    "name": "Infections"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009543",
                    "term": "Nifedipine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002121",
                    "term": "Calcium Channel Blockers"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000077264",
                    "term": "Calcium-Regulating Hormones and Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000015149",
                    "term": "Tocolytic Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12483",
                    "name": "Nifedipine",
                    "asFound": "Marginal zone",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5384",
                    "name": "Calcium Channel Blockers",
                    "relevance": "LOW"
                },
                {
                    "id": "M5381",
                    "name": "Calcium",
                    "relevance": "LOW"
                },
                {
                    "id": "M5398",
                    "name": "Calcium, Dietary",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17869",
                    "name": "Tocolytic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ChanBlk",
                    "name": "Channel Blockers"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "BDCA",
                    "name": "Bone Density Conservation Agents"
                }
            ]
        }
    },
    "hasResults": false
}